Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..1 of 1 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms.
More
Displaying 1..1 of 1 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Nov 2010 - 102 pages - $1,495
Nov 2010 - 251 pages - $1,495
Nov 2010 - 117 pages - $1,495
Nov 2010 - 297 pages - $1,495
Nov 2010 - 178 pages - $1,495
Nov 2011 - 7 pages - $3,835
Nov 2010 - 160 pages - $1,495
Mar 2011 - 29 pages - $1,000
Feb 2011 - 91 pages - $500
Dec 2009 - 53 pages - $2,000